Subject(s)
Analgesics/pharmacology , Cholecystokinin/pharmacology , Gastrointestinal Transit/drug effects , Naltrexone/analogs & derivatives , Peptide Fragments/pharmacology , Phenylurea Compounds , Sincalide/analogs & derivatives , Amino Acid Sequence , Animals , Benzodiazepinones/pharmacology , Cholecystokinin/antagonists & inhibitors , Devazepide , Gastric Emptying/drug effects , Indoles/pharmacology , Male , Mice , Mice, Inbred ICR , Molecular Sequence Data , Morphinans/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Peptides/pharmacology , Reaction Time/drug effects , Receptors, Cholecystokinin/antagonists & inhibitors , Sincalide/pharmacologySubject(s)
Indoles/pharmacology , Morphinans/pharmacology , Naltrexone/analogs & derivatives , Narcotic Antagonists/pharmacology , Receptors, Opioid/physiology , Animals , Dose-Response Relationship, Drug , Electric Stimulation , Endorphins/pharmacology , Enkephalin, D-Penicillamine (2,5)- , Enkephalins/pharmacology , In Vitro Techniques , Injections, Intraventricular , Male , Mice , Mice, Inbred ICR , Morphine/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Reaction Time/drug effects , Receptors, Opioid, delta , Vas Deferens/drug effectsSubject(s)
Analgesics , Enkephalins/pharmacology , Nociceptors/drug effects , Receptors, Opioid/drug effects , Animals , Dose-Response Relationship, Drug , Enkephalin, D-Penicillamine (2,5)- , Enkephalins/administration & dosage , Male , Mice , Mice, Inbred ICR , Nociceptors/physiology , Pain Measurement , Receptors, Opioid/physiology , Receptors, Opioid, deltaABSTRACT
A series of six synthetic octapeptides, structurally related to somatostatin, demonstrate high affinity and selectivity for mu opioid receptors in radioligand binding assays. The compounds, D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 (CTP), D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP), D-tetrahydroisoquinoline carboxylic acid (D-Tic)-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 (D-Tic-CTP), D-Tic-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (D-Tic-CTOP) and D-Tic-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (D-Tic-CTAP), were tested in vitro and in vivo for agonist and antagonist potency and selectivity. In vitro bioassays included the guinea pig ileum, mouse vas deferens and rabbit vas deferens. In vivo tests included hotplate antinociception and gastrointestinal transit inhibition, performed in mice. In vitro, all six derivatives were competitive, highly selective mu antagonists (pA2 values from 6.4-7.9). The compounds demonstrated varying degrees of intrinsic agonist activity especially in the mouse vas deferens, the least active being CTAP and D-Tic-CTAP, which showed no mu or kappa agonist actions, and delta activity only at very high (greater than 3 microM) concentrations. In vivo, none of these compounds showed antinociceptive actions when administered i.c.v. in mice. All were competitive mu antagonists in the hotplate antinociception test.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Narcotic Antagonists/pharmacology , Oligopeptides/pharmacology , Receptors, Opioid/drug effects , Somatostatin/analogs & derivatives , Animals , Dose-Response Relationship, Drug , Endorphins/pharmacology , Enkephalin, D-Penicillamine (2,5)- , Enkephalins/pharmacology , Guinea Pigs , In Vitro Techniques , Male , Mice , Mice, Inbred ICR , Rabbits , Receptors, Opioid, muABSTRACT
The opioid nature of kentsin (Thr-Pro-Arg-Lys) and its ability to alter pain perception and intestinal transit were examined. Kentsin (30,000 nM) did not inhibit electrically stimulated contractions of the guinea pig ileum (GPI) or mouse vas deferens (MVD), nor did it cause a rightward displacement of the inhibitory concentration-response curves of the mu-selective opioid agonist PL017 in the GPI or the delta-selective agonist DPDPE in the MVD. Kentsin (10,000 nM) did not displace [3H] naloxone from rat brain homogenates. These results indicate that kentsin lacks opioid agonist and mu and delta opioid antagonist properties and does not bind to opioid receptors. In vivo, kentsin produced dose-dependent analgesia in both the hotplate and abdominal stretch tests when administered intracerebroventricularly (ICV) and intrathecally but not intravenously. The central analgesic effect of kentsin was partially antagonized by the opioid antagonist naloxone. Kentsin inhibited intestinal transit in a dose-dependent manner after ICV administration only. The intestinal antitransit effect of kentsin was not blocked by pretreatment with naloxone. These results suggest that kentsin acts centrally to produce both opioid and non-opioid effects. Further, the opioid-mediated analgesic effects of kentsin involve mechanisms other than direct interaction with opioid receptors.